MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from loan
payable with related...
$18,650K
Issuance of common
shares-The2025ATMOffering
$828K
Issuance of common
shares-Employee Stock Purchase...
$1K
Cash provided by
financing activities
$19,379K
Canceled cashflow
$100K
Decrease in cash, cash
equivalents, restricted cash...
-$2,611K
Canceled cashflow
$19,379K
Accrued liabilities
$3,429K
Accounts payable
$1,653K
Interest on loan payable
to related party
$843K
Stock-based compensation
$477K
Noncash operating lease
expense
$396K
Prepaid expenses
-$44K
Interest on lease
liabilities
$34K
Depreciation of property and
equipment
$22K
Repayment of loan with
related party
$100K
Cash used in
operating activities
-$21,990K
Canceled cashflow
$6,898K
Net loss
-$25,468K
Other assets
$2,958K
Change in operating
lease liability
-$462K
Back
Back
Cash Flow
source: myfinsight.com
Aptose Biosciences Inc. (APTOF)
Aptose Biosciences Inc. (APTOF)